The clinical case of cardiac amyloidosis associated with multiple myeloma
https://doi.org/10.20538/1682-0363-2020-2-204-207
Abstract
About the Authors
E. I. TsoiRussian Federation
111A, Kievskaya Str., Tomsk, 634012, Russian Federation
Yu. V. Rogovskaya
Russian Federation
111A, Kievskaya Str., Tomsk, 634012, Russian Federation
S. V. Demyanov
Russian Federation
111A, Kievskaya Str., Tomsk, 634012, Russian Federation
V. V. Ryabov
Russian Federation
111A, Kievskaya Str., Tomsk, 634012, Russian Federation
References
1. Martinez-Naharro A., Hawkins P.N., Fontana M. Cardiac amyloidosis. Clinical Medicine. 2018; 18 (2): s30–s35. DOI: 10.7861/clinmedicine.18-2s-s30.
2. Promislow S.J., Ruddy T.D. The evolving landscape of nuclear imaging in cardiac amyloidosis. Journal of Nuclear Cardiology. 2018; 27: 210–214. DOI: 10.1016/j.jcmg.2012.10.006.
3. Luciani M., Troncone L., Monte F.D. Current and future circulating biomarkers for cardiac amyloidosis. Acta Pharmacologica Sinica. 2018: 1–9. DOI: 10.1038/aps.2018.38.
Review
For citations:
Tsoi E.I., Rogovskaya Yu.V., Demyanov S.V., Ryabov V.V. The clinical case of cardiac amyloidosis associated with multiple myeloma. Bulletin of Siberian Medicine. 2020;19(2):204-207. https://doi.org/10.20538/1682-0363-2020-2-204-207